School of Medicine
Showing 41-50 of 165 Results
-
Timothy Ellis-Caleo, MD
Clinical Assistant Professor, Medicine - Oncology
BioDr. Timothy Ellis-Caleo is a board-certified, fellowship-trained medical oncologist with Stanford Health Care. He is also a clinical assistant professor in the Department of Medicine, Division of Oncology at Stanford University School of Medicine.
Dr. Ellis-Caleo specializes in caring for people with thoracic and gastrointestinal cancers. His clinical interests include immunotherapy and precision oncology, with a focus on bringing the latest advances in cancer treatment to patients. He works closely with each patient to develop personalized treatment plans that reflect their goals, values, and individual needs while incorporating evidence-based therapies and access to innovative clinical trials when appropriate.
As a physician-researcher, Dr. Ellis-Caleo focuses on improving treatments for patients with solid tumors through translational research and clinical investigation. His research has explored the tumor microenvironment and its role in predicting response to immunotherapy, molecular biomarkers for lung cancer, and the use of artificial intelligence to improve cancer care and surveillance.
Dr. Ellis-Caleo has authored numerous peer-reviewed publications in leading medical journals, including Nature Cancer, Nature Communications, NPJ Digital Medicine, and Journal of Clinical Oncology (JCO) Precision Oncology. He has presented his research at national and international meetings, including the American Society of Clinical Oncology Annual Meeting and the World Conference on Lung Cancer.
Dr. Ellis-Caleo is a member of Alpha Omega Alpha Honor Medical Society and Sigma Xi, The Scientific Research Honor Society. -
Alice C. Fan
Associate Professor of Medicine (Oncology) and, by courtesy, of Urology
Current Research and Scholarly InterestsDr. Fan is a physician scientist who studies how turning off oncogenes (cancer genes) can cause tumor regression in preclinical and clinical translational studies. Based on her findings, she has initiated clinical trials studying how targeted therapies affect cancer signals in kidney cancer and low grade lymphoma. In the laboratory, she uses new nanotechnology strategies for tumor diagnosis and treatment to define biomarkers for personalized therapy.
-
Dean W. Felsher
Professor of Medicine (Oncology) and of Pathology
Current Research and Scholarly InterestsMy laboratory studies the molecular basis of cancer with a focus on understanding when cancer can be reversed through targeted oncogene inactivation.
-
George A. Fisher Jr.
Colleen Haas Chair in the School of Medicine, Emeritus
Current Research and Scholarly InterestsClinical expertise in GI cancers with research which emphasizes Phase I and II clinical trials of novel therapies but also includes translational studies including biomarkers, molecular imaging, tumor immunology and development of immunotherapeutic trials.
-
James Ford
Professor of Medicine (Oncology) of Genetics and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsMammalian DNA repair and DNA damage inducible responses; p53 tumor suppressor gene; transcription in nucleotide excision repair and mutagenesis; genetic determinants of cancer cell sensitivity to DNA damage; genetics of inherited cancer susceptibility syndromes and human GI malignancies; clinical cancer genetics of BRCA1 and BRCA2 breast cancer and mismatch repair deficient colon cancer.
-
Kristen N Ganjoo
Professor of Medicine (Oncology)
Current Research and Scholarly InterestsGiant cell tumor of the bone
Gastrointestinal stromal tumors
Soft tissue sarcoma
Osteosarcoma
